Offered paper: The SARS-CoV-2 exoribonuclease - a target for antiviral drug development and combination therapy

Victoria Easton (University of Leeds, UK)

12:33 - 12:45 Wednesday 06 April Morning

+ Add to Calendar

More sessions on Registration